Abstract PR010: <i>CDK12</i> loss promotes prostate cancer development while exposing vulnerabilities to paralog-based synthetic lethality

Jean C. Tien, Arul M. Chinnaiyan, Yuping Zhang et al.|Molecular Cancer Therapeutics|2024

Cited by 0